Conditions
Anticoagulation safety monitoring
Baseline checks, follow-up monitoring, and escalation triggers for outpatient anticoagulation care.
Last reviewed 2026-02-07|anticoagulation | safety | vascular
Baseline assessment
- Confirm indication, treatment phase, and intended treatment duration before starting or changing therapy.
- Review bleeding history, renal function trajectory, liver function concerns, and adherence reliability.
- Reconcile interacting medications (including over-the-counter NSAIDs and herbal supplements).
Initial workup
- Capture baseline CBC, renal function, and clinically indicated liver tests before major therapy changes.
- Document weight, age, and relevant comorbidities that affect dosing safety.
- Verify anticoagulation education readiness and follow-up access.
First-line management
- Choose regimen and dose using current guideline-aligned indication-specific pathways.
- Provide counseling on missed doses, bleeding warning symptoms, and when to seek urgent care.
- Use the same monitoring framework at every follow-up to reduce omission risk.
Red flags
- Active major bleeding, hemodynamic instability, or signs of intracranial hemorrhage.
- Severe renal deterioration with uncertainty about safe continued dosing.
- Recurrent falls, major drug interactions, or inability to maintain safe medication use.
Referral triggers
- Complex comorbidity, recurrent bleeding risk, or recurrent thrombosis despite treatment.
- Persistent uncertainty around indication, duration, or agent choice.
- Need for specialist-guided anticoagulation strategy beyond primary-care scope.